De-implementation of low-value bronchiolitis practices showed sustained adherence two years post-trial in a cluster RCT follow-up.
This cluster randomised controlled trial (cRCT) follow-up study evaluated the sustainability of de-implementing low-value practices in bronchiolitis management. The intervention involved hospitals stopping chest radiography, salbutamol, glucocorticoids, antibiotics, and epinephrine use, compared with control hospitals that did not receive this intervention. The population included 3299 infants one year post-trial and 1689 infants two years post-trial across 26 Australian and New Zealand hospitals.
Two years after the trial completion, adherence with no use of the five low-value practices was 80.9%. The adjusted predicted adherence was 80.8%, with a 95% CI of 77.4% to 84.2%. The estimated risk difference from the cRCT outcome was -3.9% (95% CI: -8.6% to 0.8%), which was fulfilling the a priori definition of sustainability defined as no more than a <7% decrease to any level of improvement in adherence for all five low-value practices.
Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. Funding or conflicts of interest were also not reported. The study provides evidence for sustainability in de-implementing low-value care in bronchiolitis management, though the lack of safety reporting limits the ability to assess long-term risk in this setting.